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ABSTRACT 
 
Spatial Analysis of County Level Drug Overdose Deaths and Associated Factors, Over Two 
Time Periods in the United States  
 
By 
 
SUNANDA SARKAR 
 
April 18, 2019 
 
 
INTRODUCTION: Recently, drug overdose is being considered as an important public health 
issue, the magnitude of which is yet to be adequately explored. The United States is experiencing 
a wide range of drug overdose problems over the past decades, where fatal overdoses have 
tripled from 1999 to 2016. Geographic approaches to drug overdose death research have 
emerged in recent years. Studies demonstrated that overdose mortalities are not equally 
distributed across different geographic areas. Therefore, it is important to consider geographic 
variations to inform effective prevention and treatment of drug overdoses and prevent premature 
deaths. 
 
AIM: The aim is to explore spatial distribution of county level drug overdose death rates in the 
contiguous U.S. over two 5-year time intervals (2007-2011 and 2012-2016); identify and 
evaluate the extent to which the county level socio-economic and socio-demographic factors are 
associated with the spatial patterning and explain it. 
 
METHODS: Exploratory spatial cluster analysis was performed to determine whether patterns of 
observed drug overdose mortality are spatially random or not over two time periods. Both 
traditional and Empirical Bayes standardization methods were used for spatial autocorrelation 
test. To determine any change over time, observations in the data are stacked based on time. 
Time stacked spatial regression analysis was performed to determine the associations between 
several county level socio-economic and socio-demographic factors and drug overdose death 
rates in the U.S. 
 
RESULTS: Mean drug overdose death rate increased from early to late time period. Results 
indicates the presence of significant (at 5% significance level) spatial autocorrelation among the 
adjacent counties in the drug overdose death rates, and this spatial pattern differs in two time 
periods. Finally, spatial regression indicates that the effect of different contextual factors are 
heterogenous over time and across different population. 
 
CONCLUSION: Findings may help inform efforts to prevent, diagnose or treat drug overdoses 
ahead of time, thus prevent premature deaths by understanding the geographic variations and 
identifying the areas with growing burdens. Studies focusing on similar associations across 
different age-groups and insured group may provide better insight. 
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Chapter I 
Introduction 
1.1 Overview  
Recently, drug overdose is being considered as an important public health issue, the 
magnitude of which is yet to be adequately explored. However, until now it was considered to be 
substance abuse, crime under law, or sin per holy books, but not as injury or a public health 
problem (Paulozzi, 2007; Martins, Sampson, Cerdá, & Galea, 2015). Worldwide, the drug 
overdose mortality has been increasing considerably. For instance, drug overdose mortality in 
Oceania (mainly consists of Australia and New Zealand) is about 2.5 times the global average 
(WDR 2017, n.d.). Similarly, other countries are also experiencing higher rates than the past. 
Many countries in Europe, including England, Sweden, Norway, Ireland and Estonia, have 
higher rates for drug mortality than the previous years; Scotland has the highest rate among the 
countries in Europe (IOAD, n.d.). However, approximately a quarter of worldwide drug 
overdose deaths happen in the United States— which is the highest among all the countries in the 
world (WDR 2017, n.d.). While comparing the mortality trends from drug overdose from 2001 to 
2015 among the 13 OECD (Organization for Economic Co-operation and Development) member 
countries, a recent study found the similar result of the United States having the highest mortality 
rate from drug overdose in 2015 (Chen, Shiels, Thomas, Freedman, & de González, 2018).  
Each day, drug overdose accounts for 174 deaths in the United States (Jalal et al., 2018). 
According to a CDC (Center for Disease Control and Prevention) report published on January 1, 
2016, there was a 137% increase in the drug overdose death rate in the United States since 2000 
(Rudd, Aleshire, Zibbell, & Gladden, 2016). Another article reported that age-adjusted death rate 
from drug overdose approximately tripled from 1999 to 2016 (i.e., from 6.1 to 19.8 per 100,000 
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population) (Hedegaard, 2017). Jalal et al. (2018) examined all drug overdose mortality in the 
U.S. from 1979 to 2016 and found the growth to be exponential. This finding is consistent with 
another report published from the CDC under National Center for Health Statistics (NCHS) 
(Rossen, Bastian, Warner, Khan, & Chong, 2017). To put this in perspective, this mortality from 
drug overdose now outnumbers the deaths from road traffic accidents and violence (WDR 2017, 
n.d.). Thus, the United States is experiencing a wide range of drug overdose problems over the 
past decades leading to increased economic damage, and this has become an emerging public 
health issue.  
Definition of drug overdose 
Drug overdose as defined by the literature is “when someone collapses, has blue skin, has 
convulsions, has difficulty breathing, loses consciousness, cannot be woken up, has a heart attack 
or dies while using drugs” (Bohnert, Tracy, & Galea, 2012, p. 3). This definition is also used by 
other literatures (McGregor, Darke, Ali, & Christie, 1998; Ochoa, Hahn, Seal, & Moss, 2001; 
Martins, Sampson, Cerdá, & Galea, 2015). This definition implies to any drug causing overdose 
whether available through prescriptions or illicit, and the majority of fatal overdoses involve 
opioids. However, prescription opioids are responsible for more overdose deaths (approximately 
70%) than any illicit drug (Florence, Luo, Xu, & Zhou, 2016; U.S. DOJ, 2018). Whether 
prescription or illicit, most of these premature drug overdose deaths are preventable (WDR 2017, 
n.d.). 
Economic burden of drug overdose 
 The economic burden of all drug overdoses, fatal and non-fatal in the U.S. is huge, and 
total estimates are yet to be explored. These burdens include costs of healthcare, lost 
productivity, treatment of addiction, criminal justice involvement, and so on (Abuse, 2019). 
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Among the recent studies, the largest estimate was published by Florence et al. (2016), who 
estimated the prescription opioid overdose, abuse and dependence in the U.S. in 2013. The 
authors found the total estimated cost to be over $78.5 billion for the year 2013. Among the 
aggregated cost, a little over one third (over $30 billion) was expensed for health care. Again, 
fatal overdoses accounted for a little over one quarter (around $21 billion) of the total cost 
(Florence, Luo, Xu, & Zhou, 2016). The authors also found that about 14 percent of the total cost 
is funded by public health insurance programs and more from other public sources.  
Geographic variations of drug overdose 
 Geographic approaches to drug overdose death research have emerged in recent years. 
Studies demonstrate that drug overdose mortalities are not equally distributed across different 
geographic areas or population subgroups. It is important to consider geographic variation in 
order to inform effective prevention, diagnosis and treatment of the condition and to reduce the 
inequalities (Dwyer-Lindgren et al., 2018). Different studies focus on different aspects like some 
studies identify state level geographic variations of mortality related to opioid and heroin only 
(Ruhm, 2017), whereas other studies concentrate on mortalities from drugs, alcohol and even 
interpersonal violence altogether (Dwyer-Lindgren et al., 2018). However, the geographic 
patterns of drug overdose mortality rates involving all types of drugs (not including alcohol) 
focusing on smaller geographic scales like counties are yet to be explored. Detailed evaluation of 
patterns and associated factors may help understand the problem more and identify approaches 
that can be applied to prevent premature deaths. This study plans to examine any possible spatial 
pattern at smaller geographic scales (the county) and associated factors of drug overdose deaths 
with spatial analysis. 
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1.2 Study objectives 
 The objective of this study is to explore the spatial distribution of drug overdose death 
rates i.e., presence of any possible geospatial clustering at the county level in the contiguous 
United States over two 5-year time intervals (2007-2011 and 2012-2016), to identify the county 
level factors associated with this spatial patterning, and to evaluate the extent to which these 
spatial patterns are explained by county-level factors. To identify the geospatial clusters of drug 
overdose mortality rates, this study utilizes two methods: The Traditional method of spatial 
cluster analysis using raw/crude rates and the Empirical Bayes standardization method using 
smoothing to reduce variance instability caused by small-population areas. 
1.3 Research questions 
The proposed research questions for this study are as follows:  
1. Are the county level drug overdose death rates in the United States spatially 
correlated among adjacent counties? 
2. Do the geospatial patterns differ in the two time periods? If so, how much has the rate 
increased over time, and where geographically are the greatest increases?  
3. Do any socio-economic or socio-demographic factor(s) have significant associations 
with the observed overdose death rates? 
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Chapter II 
Review of the Literature 
This study evaluates the spatial distribution of drug overdose death rates at the county 
level in the contiguous United States over two 5-year time intervals (2007-2011 and 2012-2016) 
and presence of any association with county-level socio-economic or socio-demographic factors. 
Considering the alarming rise in drug overdose deaths stated before, there are several 
contributing factors that have been found in the literature. For example: insurance coverage, 
poverty level, employment status, racial background in conjunction with poverty level and 
urbanization, or declining population in the county may be important predictors. The following 
literature review provides an overview of the drugs and types of drugs commonly involved in 
overdose mortality, and how different socioeconomic or sociodemographic factors linked to the 
epidemic have been described in published literature. 
2.1 Drugs commonly involved in overdose 
A recent issue of National Vital Statistics Report published from the U.S. centers for 
disease control and prevention (CDC) in December 2018 identified the drugs that were most 
commonly involved in drug overdose deaths in the United States during 2011 to 2016. 
According to this report, drugs that were most commonly involved in the drug overdose deaths 
fall into three different categories: 1) Opioids: fentanyl, heroin, hydrocodone, methadone, 
morphine and oxycodone; 2) Benzodiazepines: alprazolam and diazepam; and 3) Stimulants: 
cocaine and methamphetamine (Hedegaard, Bastian, Trinidad, Spencer, & Warner, 2018). 
Among the 10 most commonly involved drugs (fentanyl, heroin, hydrocodone, methadone, 
morphine, oxycodone, alprazolam, diazepam, cocaine, methamphetamine) identified by the 
report, oxycodone was the highest drug involved in the overdose deaths in 2011, heroin in 2012-
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2015, and fentanyl in 2016. On the other hand, cocaine consistently ranked second or third 
(Hedegaard, Bastian, Trinidad, Spencer, & Warner, 2018). Among all drug overdose deaths, 
opioids account for approximately 68% of deaths (Scholl, Seth, Kariisa, Wilson, & Baldwin, 
2018). This paper studies overdose deaths from all types of drugs and drug classes combined as 
the underlying cause of death, available from the CDC WONDER website. Details are described 
in the methods section. 
2.2 Overdose related to prescription drugs and insurance coverage 
The literature addressing the drug overdose epidemic was primarily focused on death by 
different types of illicit drugs. However, prescription drugs have proved to have a strong 
connection to the overdose deaths in the United States over the past several years, and opioids 
belong in the top three categories of prescribed drugs in the U.S. (Unity Behavioral Health, 
2017). Report shows that there has been a significant increase in the use of prescription opioid 
analgesics among the U.S. adults since 1999 (Frenk, 2015). Prescription opioids are responsible 
for more than half of the fatal overdoses in the United States currently (U.S. DOJ, 2018). 
Prescription overdoses usually have an innocent origin as a prescription for a genuine condition. 
However, lack of information regarding the addictive nature of the drug makes it difficult for the 
individual to realize ahead of time that he or she may become addicted. Thus, there is a medical 
component in the causality of this epidemic (Smith, 2017). More use of prescription drugs leads 
to more morbidity related to overdose. Studies found associations between increased opioid 
prescriptions and emergency department visits due to opioid overdose (Dasgupta et al., 2006; 
Wisniewski, Purdy, & Blondell, 2008). This morbidity or ED visits are related to the potency of 
the drugs i.e., higher for high potency opioids and lower for low potency opioids (Dasgupta et 
al., 2006). Similar findings demonstrated by another study are that increased numbers of 
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prescriptions lead to higher sales which in turn is correlated to related overdose deaths (Modarai 
et al., 2013).  
While considering the potential influences of different stakeholders on this epidemic, 
several have been identified: pharmaceutical companies, distributors, prescriber physicians, 
health insurers and pharmacies. Drug makers and pharmaceutical companies are given more 
attention in this regard. There is evidence that marketing of opioid products to the physicians by 
the pharmaceutical companies is associated with higher rates of seeking treatment for addiction 
and higher rates of mortality from the prescription opioid overdoses (Smith, 2017; Hadland, 
Rivera-Aguirre, Marshall, & Cerdá, 2019). 
Less attention has been given to the health insurers and pharmacy benefit managers. 
There seems to be a nexus between the insurers and the pattern of opioid prescribing and related 
overdose due to addiction. Studies done in different states found a substantial growth in the use 
of prescription opioid drugs among the population covered by insurance, specifically public 
insurance. For example, a study in North Carolina showed higher rate of death among the 
Medicaid beneficiaries from prescription opioid overdose than the general population (Whitmire 
& Adams, 2010). Another study in Washington state demonstrated that almost half of the opioid 
overdose deaths occurred among Medicaid enrollees even though a very small percent of the 
State’s total population were enrolled in Medicaid (CDC, 2009). Changes in the payment 
patterns for these drugs has also been noticed. According to one study, the financing pattern for 
opioid pain relievers has shifted substantially from consumers’ out-of-pocket to insurers during 
the 1999-2012 period. This study also found little change in total expense on opioid drugs, while 
there was a huge increase in the number of drugs prescribed, suggesting a shift towards the less 
expensive drugs (Zhou, Florence, & Dowell, 2016). 
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2.3 Overdose related to socioeconomic and socio-demographic determinants 
Although blame for the overdose mortality mostly goes to the supply side (those who 
make the drugs available), the demand side of this crisis, which is related to people using the 
drugs, has not been adequately explored. Several studies focused on the overdose related 
mortality with different socio-economic and socio-demographic determinants. Research 
conducted in a few U.S. states and among Medicare enrollees showed that areas with higher 
poverty level have higher concentrations of opioid prescription rates and related mortality, or 
opioid and heroin overdose-related hospital discharges (Grigoras et al., 2018; Pear et al., 2019). 
Studies also found that rural areas have higher opioid prescription rates along with overdose rates 
(Paulozzi & Xi, 2008; Grigoras et al., 2018). As these areas have a greater proportion of Non-
Hispanic white population, the mortalities are concentrated among them (Rudd, 2016; Grigoras 
et al., 2018). A study conducted on racial disparities for the opioid epidemic found an increasing 
rate of mortality among the Non-Hispanic white population since 1979, while the rate remained 
stable for the Non-Hispanic black population until 2010. After 2010, this growth was rapid for 
the both populations (Alexander, Kiang, & Barbieri, 2018). However, this study only looked at 
Black and White populations in regards of racial disparity on mortality. Frenk (2015), on the 
other hand, focused on ethnic differences in opioid analgesics use from 2007 to 2012 and showed 
that the Non-Hispanic population (both white and black) are more likely to use opioid analgesics 
than the Hispanic population.  
Economic factors are other determinants that might have an association with drug 
overdose mortality. Studies done in two different areas (Luxembourg and New York City) found 
that unemployment, unstable income, or unequal income distribution are likely to have an impact 
on fatal overdoses (Galea et al., 2003; Origer, Le Bihan, & Baumann, 2014). A study on opioid 
poisoning-related hospital discharge done in California found a positive association between 
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opioid poisoning and lower household income (Cerdá et al., 2017). Brown & Wehby (2017) 
examined state level drug overdose deaths and associated economic conditions. They found that 
economic downturns may increase opioid related deaths. A few studies also showed how 
different economic measures, alone or in groups, are associated with illicit drug use and related 
mortality. For example, Carpenter, McClellan, & Rees (2017) showed that higher state level 
unemployment was related to increased use of prescription pain medication and other substance 
use disorders, because stress of losing a job was associated with higher use of these drugs. This 
finding is consistent with a qualitative study done in a now deindustrialized area of Pennsylvania 
which once was a global center of steel production. This study demonstrated how frustration, 
lack of opportunity, and social isolation due to losing jobs led to the local overdose crisis 
(McLean, 2016). 
2.4 Geographic variations of overdose mortality 
Few studies have explored overdose mortality by specific geographic regions and time 
period. A study done in California state demonstrated opioid poisoning to be concentrated in 
rural areas and suggested a spatial spread (termed as ‘spatial contagion’) from rural and suburban 
to urban areas. This study also identified a spatial association between income and opioid related 
hospital discharges (Cerdá et al., 2017). Another study on the geospatial distribution patterns of 
death from heroin at the county level in the U.S. showed a shift from the West Coast in 2000 to 
New England and Mid-Atlantic regions, the Great Lakes and the Central Ohio Valley by 2014 
(Stewart, Cao, Hsu, Artigiani, & Wish, 2017), which indicates a change in the pattern or 
evolution over space and time. Another county level spatial study examined all drug poisoning 
deaths, but the time period was limited to 2007-2009 (Rossen, Khan, & Warner, 2014). This 
study identified several hotspot and cold-spot clusters for drug poisoning deaths across the U.S. 
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using a K-nearest neighbor approach. The main hotspots were located in the North Pacific coast, 
the Southwest, Appalachia, and along the Gulf coast. The main cold-spots were located across 
the Central Plains and Texas (Rossen, Khan, & Warner, 2014). These studies give evidence 
regarding those locations where the burdens are higher. Studying this problem over a longer 
period and comparing it over both time and space will further elucidate the geography of drug 
overdose deaths and help address the growing burden.  
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Chapter III 
Methods and Procedures 
3.1 Data sources 
  This study focuses on the county-level drug overdose mortality data in the contiguous 
U.S and the relationship with county-level contextual factors, and comparison over two time 
intervals using spatial analysis. A good quality spatial data is one which is based on population 
data or spatially representative data, and not just a random sample from the population which 
uses the non-spatial sampling method (Mobley, 2013). Good quality spatial data or 
geographically referenced data is required to conduct spatial analysis for population health 
research, through which we can evaluate the spatial trends present among the areas in the context 
of the question asked. Therefore, it helps to identify the areas with greatest concerns or 
populations at risk. This information in turn is useful for applying public health policy in the 
areas of concern or where the intervention is needed most.  
 Data on county level drug overdose mortality in the contiguous U.S. are obtained from 
CDC WONDER (Wide-ranging Online Data for Epidemiologic Research), an online database 
developed by Centers for Disease Control and Prevention (CDC) released December 2017. This 
database includes all mortality data by underlying cause of death. Thus, the data are available in 
the file “Underlying Cause of Death 1999-2016”. The data file includes national mortality data 
i.e., raw count of drug overdose deaths per county per year, total population size per county, year 
code, underlying cause of death (UCD) code, county and state names, and geographic identifiers 
(county FIPS codes). The mortality data are based on the single underlying cause of death 
available in the death certificates for the U.S. residents (CDC, n.d.). The underlying cause of 
death is determined by International classification of disease, 10th revision (ICD-10), defined by 
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World Health Organization. Based on the ICD-10 classification, drug overdose deaths data over 
two-time intervals, 2007-2011 and 2012-2016, are downloaded from the CDC website for this 
study. 5-years period aggregated mortality data per county are collected to maximize the number 
of the counties with reported mortality rate. As of May 23, 2011, data representing less than 10 
counts of death or population per county are suppressed due to CDC privacy policy (CDC, n.d.). 
Therefore, counties with less than 10 counts of death exhibited blank values which are replaced 
with zero for this study. The population estimates are taken from the U.S. Census Bureau based 
on census counts. 
The county level contextual factors for predictor variables are compiled from various 
sources- Small area health insurance estimates (SAHIE) and Small area income and poverty 
estimates (SAIPE) program of U.S. Census Bureau, Bureau of Labor Statistics, GeoDa center 
calculated data, and USDA ERS (United States Department of Agriculture, Economic Research 
service). SAHIE and SAIPE programs are purposed to develop model-based estimates of county 
and state level health insurance coverage, poverty and income statistics (Bureau, n.d.). SAHIE 
provides state and county level data on number and percentages of insured and uninsured people 
by age, sex, race/ ethnicity and income level per year. SAHIE data are usually used to assess 
geographic variations and changes over time in the health insurance coverage in the United 
States (Bureau, n.d.). County level percent of uninsured people (total population < age 65 years) 
data are obtained for the two-year periods (2005 and 2014). SAIPE provides annual estimates of 
income and poverty at school-district, county and state level. The main purpose is to locate 
poverty-stricken/ destitute areas to help allocating the federal funds and local programs (Bureau, 
n.d.). Data on county level estimated percent of total people in poverty are collected for the 
income years of 2005 and 2014.  
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Data on unemployment are obtained from the Local Area Unemployment Statistics 
(LAUS) program of Bureau of Labor Statistics. This is a federal-state cooperative program 
providing data related to employment and unemployment for different specified areas (LAUS, 
n.d.). Annual averages of county level unemployment rate data are available in this database and 
are obtained for two different years for this study (2005 and 2015). Economic Research Service 
(ERS) of USDA (United States Department of Agriculture) is complementing USDA’s research 
mission by broadening the fields of research on various fields like economy and policy relevant 
themes to highlight economic and social characteristics. Population loss typology code is located 
under policy relevant types of county typology codes (USDA, n.d.). Population loss typology 
code data are collected for the two-year periods (2004 and 2015).  Data on Poverty rate by race 
or ethnicity and urbanization are obtained from GeoDa Center. Poverty rate is measured as 
percent of total population in poverty for each of the three races (Black, White and Hispanic) and 
for each area (urban and rural) for two different periods (2000 and 2005-2009) by GeoDa center. 
For earlier period, this rate is calculated from census 2000 tract level data and for later period, 
this rate is calculated from American Community Survey’s (ACS) aggregated tract level data for 
2005-2009 (GeoDa, n.d.).  
3.2 Conceptual model/ framework for drug overdose mortality 
 The conceptual model for this research is adapted based on the published literatures on 
drug overdose deaths in the United States. The variables included in this model are: drug 
overdose death rates (2007-2011 and 2012-2016), uninsured rate (2005 and 2014), 
unemployment rate (2005 and 2015), overall poverty rate (2005 and 2014), poverty rate by race/ 
ethnicity and urbanization (2000, 2005-2009 aggregated), and population loss index from the 
county (2004 and 2015). All these variables are county level variables. The main objective is to 
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explore the spatial distribution of drug overdose deaths to identify any spatial autocorrelation 
present among the adjacent counties. In addition, to have a better picture on the distribution of 
the epidemic of drug overdose deaths across the space and time, the outcome is compared over 
time based on the predictors. Therefore, all the variables collected are over two time periods as 
stated above.  
The outcome in this model is county level drug overdose death rate. Most of the 
literatures described the drug overdose death data based on International Classification of 
Disease (ICD-10), 10th revision of underlying cause of death. According to this death classes, the 
death codes that fall under drug overdose deaths class are: unintentional drug poisoning/ 
overdose (X40- X44), suicide drug poisoning/ overdose (X60- X64), homicide drug poisoning/ 
overdose (X85), and undetermined drug poisoning/overdose (Y10- Y14) (CDC, n.d.). Among 
these classes, unintentional drug overdose deaths hold the highest rank recently with about 80%-
86% of drug overdose deaths followed by suicide (8%-13%) (Hedegaard, 2017). However, to 
have a detailed idea on the overall picture, all the codes are combined to get all types of drug 
overdose deaths together for this study. The time period (2007-2011 and 2012-2016) for the 
outcome variable is chosen because this was the most recent available data in the CDC 
WONDER website when collected. 5 years interval is enough to over-ride privacy concerns and 
allow us to obtain the data. Moreover, Affordable Care Act is assumed to play a major role in 
many aspects of the insurance coverage and associated factors related to prescription medications 
based on published literature (Smith, 2017).  
The exploration of spatial distribution of drug overdose deaths are enriched with 
additional examination of factors that are assumed to be associated with the clustering. So, data 
for the predictor variables are also obtained for two time intervals. Percent of total population 
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uninsured in the county as uninsured rate is included to determine the role insurance coverage in 
the drug overdose mortality (CDC, 2009; Whitmire & Adams, 2010; Modarai et al., 2013; Burns, 
2017). From the perspective of socio-economic and socio-demographic determinants, this study 
uses unemployment rate, overall poverty rate, poverty rate by race/ ethnicity and urbanization 
variable. Unemployment rate and poverty rate are determinants of economic conditions playing 
role in the associated factors of drug overdose (Brown & Wehby, 2017; Carpenter, McClellan, & 
Rees, 2017). However, literature showed mixed results on these determinants; thus, included in 
the conceptual model for more elaboration. Poverty rate by race/ethnicity and urbanization 
variables are included to demonstrate the racial disparities based on urbanization (rural versus 
urban living). Literature showed the role of racial disparities along with living area on drug 
overdose and related mortality (Paulozzi & Xi, 2008; Alexander, Kiang, & Barbieri, 2018; 
Grigoras et al., 2018). Population loss index is also included in the conceptual model assuming 
that social isolation and marginalization might have influence on the drug addiction or overdose 
(McLean, 2016). 
However, the associations with different contextual factors examined in many different 
published studies ignored any spatial perspective, which is invariably present in socio-economic 
problems (Koschinsky, n.d.). Study of these factors should consider potential spatial dependence 
or autocorrelation across the areas, as these are usually shared among people across county 
boundaries causing spatial correlation. Ignoring spatial autocorrelation may create biased or 
inconsistent estimates, by violating the assumption for ordinary least square (OLS) regression 
that the observations under analysis are statistically independent (Mobley et al., 2011; Mobley, 
n.d.). Thus, examining the factors in consideration of potential spatial autocorrelation among 
adjacent counties (smaller areal level) and a larger geographic scope including the entire U.S., 
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with comparisons over time can provide us with valuable information to help control this 
epidemic. Description of all the variables with type, metrics, sources and years are summarized 
in Table 1. 
3.3 Data processing and Measures  
All the data are downloaded and merged into the Microsoft Excel workbook. The 
outcome variable is county level drug overdose death rates in the contiguous U.S. over two time 
intervals, 2007-2011 and 2012-2016, which is continuous. For the outcome variable, 5-years 
period aggregated death counts per county are downloaded to maximize the number of the 
counties with reported mortality. Counties with suppressed data that exhibited blank values are 
replaced with zero. Total population count per county is downloaded for all counties. Crude 
Mortality rates are calculated from total death count for a county aggregated over the 5-year 
period and size of the population residing in that county in the MS excel using the formula 
below: 
Drug overdose death rate 
  = (Number of total drug-related deaths per county/ population size of that county) * 
100,000 
Drug overdose death rates are calculated for two different periods, 2007-2011 and 2012-2016, 
and a single rate is obtained for every county in each group. Due to the suppressed data, this file 
has 1914 counties with positive death rates in 2007-2011, and 2032 counties with positive death 
rates in 2012-2016. Raw counts for drug overdose death and population counts per county are 
kept in the data file to be used in the Empirical Bayes standardization method of clustering. 
The independent variables are un-insured rate, unemployment rate, overall poverty rate, 
poverty rate by race or ethnicity and urbanization, and a population loss index. All are county 
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level variables and in two time intervals. Un-insured rate is a continuous variable. It is measured 
as percentage of total population under 65 years of age without health insurance and selected for 
the year 2005 and 2014 from SAHIE program of US Census Bureau. Overall poverty rate is 
another continuous variable, which is measured as percent of total population in poverty for the 
income year and selected for the year 2005 and 2014. Annual averages of county level 
unemployment rate data for the year 2005 and 2015 are downloaded, which is also a continuous 
variable. The population loss index is coded as dichotomous variable. This variable indicates 
whether the county has lost population over recent years, where 1= yes and 0=no. The data are 
selected for the year 2004 and 2015. Poverty rate by race or ethnicity and urbanization is 
measured as percent of population in poverty for each of the three races (Black, White and 
Hispanic) and for each area (urban and rural). These variables were calculated by the GeoDa 
center. Since the data were already aggregated by the GeoDa center, thus are directly collected 
for this study without further calculation. These are also continuous variables.  
The merged data file from MS excel is joined with county geographic shapefile from the U.S. 
Census Bureau using unique county FIPS codes in the QGIS software. FIPS or the Federal 
Information Processing Standards are unique numeric codes set for all the counties in the U.S. as 
identification code (ESRI, n.d.). These FIPS codes are included in the data file as a unique 
identifier and to be used as geocoding tools to link the data to map. This process in turn helps 
creating maps in the QGIS and performing regression analysis in the GeoDa software. Since 
spatial continuity is the basis for spatial regression analysis, Alaska, Hawaii and other spatial 
islands are excluded from the dataset. Therefore, the final dataset contains 3106 U.S counties. 
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3.4 Statistical analysis 
After data cleaning and measures creation, descriptive analysis of the variables used in 
the model is performed in the SAS software, version 9.4 (SAS Institute, Cary NC), for both early 
and late period. A summary of the descriptive statistics is reported in the Table 2.  
QGIS is an open-source Geographic Information System (GIS) software which is used to 
create, edit, analyze, visualize and publish geospatial information (QGIS, n.d.). In addition to the 
descriptive analysis, QGIS software 3.2 is used to examine and create translational maps to 
visually demonstrate the trends over time in the two-periods drug overdose death rates (outcome 
variable) by county (QGIS, 2018). Graduated classification (quantiles as breaks) and sequential 
color schemes are used for these mapping. The same cut points are used in two maps for both 
periods to compare geospatial patterns where rates have increased or decreased. Both maps are 
shown in Figure 1. Mapping is used also to translate the findings of local spatial autocorrelation 
(LISA) among the adjacent counties for both the traditional method and Empirical Bayes 
standardization method for drug overdose mortality.  
GeoDa is a spatial analytic software, also free and open-source tool, which allows insight 
in “spatial data analysis by exploring and modeling spatial patterns” (GeoDa, n.d.). Exploratory 
spatial data analysis to explore presence of any spatial autocorrelation (both global and local) is 
done in GeoDa (Anselin, Syabri, & Kho, 2006). Spatial autocorrelation indicates how features 
among neighbors of close proximity are similar to each other as geographic features usually tend 
to be (ArcGIS, n.d.). Other data processing like building of stacked data set on time for 
performing time stacked regression analysis is also done in Geoda software. Confirmatory spatial 
data analysis i.e. model building for spatial regression is performed in GeoDa Space (Anselin & 
Rey, 2014).  
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Traditional method and Empirical Bayes standardization method of LISA clustering 
 Working with variables that are rates or proportions might experience a potential problem 
in distribution like identification of false outliers while mapping. This occurs due to variance 
instability which is an intrinsic quality of rates. A reason behind this is varying population 
densities across the cases (GeoDa, n.d.). Empirical Bayes standardization method is suggested to 
get rid of spurious outliers and to get robust measures for spatial autocorrelation by using the 
concept from ‘Bayesian shrinkage estimator’. This method accounts for variance instability 
caused by small population size in the denominator of the rate variable by transforming the crude 
rate to have a mean of zero and unit variance (GeoDa, n.d.). Since the outcome variable in this 
study is rate variable (drug overdose death rate) and population densities across the U.S. counties 
are not similar, Empirical Bayes standardization approach could alleviate small area estimation 
problem while analyzing spatial patterns. In this study, both traditional method and Empirical 
Bayes standardization method are used to identify spatial autocorrelation among the adjacent 
U.S. counties for drug overdose death rates. Translational maps are created based on the findings 
from two different methods. The traditional method uses the formula described in the previous 
section to calculate the raw rate. Calculated raw rate is then used in the LISA clustering analysis. 
For Empirical Bayes standardization estimation of local clusters, raw counts of drug overdose 
death in the county are used as the ‘event variable’ and population size in the county is used as 
‘base variable’ in the GeoDa software. “LISA for EB rate” option in GeoDa software is selected 
and the software performs the clustering analysis by transforming the rate variable behind the 
scene.  
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Spatial Regression Analysis 
 Spatial relationship can be examined, explored and modeled by spatial regression 
analysis. It also helps to explain factors behind the observed spatial patterns (ArcGIS, n.d.). As 
described in the previous section, unlike ordinary least square (OLS) regression, both the 
dependent and independent variables under analysis may not be independent across the 
observations, necessitating use of spatial regression analysis. This spatial autocorrelation can be 
the result of two spatial stochastic processes- 1) ‘substantive dependence’ where dependence is 
present in the dependent variable and lag model is required for correct specification; and 2) 
‘nuisance dependence’ where dependence is present in the error term, and the error model is 
required for correct specification (Mobley, n.d.). In the first case, ignoring the spatial 
autocorrelation among the adjacent counties in the outcome variable can lead to biased effect 
estimates by overestimating the effect of predictors, which can be corrected using spatial lag 
regression analysis (Mobley et al., 2011). In the second case, not accounting properly for the 
spatial error process in the regression can lead to biased standard errors and misleading statistical 
inference. Therefore, as a first step, the presence of any spatial autocorrelation in the dependent 
variable (drug overdose death rate) is explored by global and local indices of spatial 
autocorrelation (Moran’s I and LISA) in GeoDa software. For this study, both traditional method 
and Empirical Bayes standardization method are used to determine the presence of spatial 
autocorrelation in the dependent variable. First, to identify the neighbors of a county spatial 
weights are defined by the queen contiguity where counties that share a common boundary (a 
common edge or vertex) are considered as neighbors (GeoDa, n.d.). Univariate global Moran’s I 
provides the information on spatial randomness. The null hypothesis is the death rates are 
spatially random among the counties. Rejection of the null indicates that spatial autocorrelation 
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is present among the adjacent counties. From the analysis in this study, univariate global 
Moran’s I statistics suggest presence of spatial autocorrelation in the outcome in both early and 
later period for both traditional and Empirical Bayes standardization methods. Moran’s I 
statistics for both methods are shown in Table 3.  
While univariate global Moran’s I suggests whether there is existence of any spatial 
clusters or not, it does not specify the exact location of the clusters. Univariate LISA (Local 
Indicator of Spatial Association) is used to detect the presence of local clustering or association 
in space. Here, LISA first finds the actual correlation between a county’s value and average of 
the neighboring counties’ values (also known as spatial lag) for the outcome variable. Then, 
LISA performs a simulation analysis for correlation of the same variable between a set of 
randomly selected counties as neighbors other than real spatial neighbors and the same county in 
question, which is done up to 999 times. This correlation is compared with the actual correlation 
to see the significance i.e., whether the actual correlation falls in far in the tail of distribution 
(Anselin, 1995). LISA statistics show four types of geographical clustering- hotspots or high-
high (significant spatially autocorrelated clusters of high values in the outcome variable between 
a county and the neighbors); cool spots or low-low (significant spatially autocorrelated clusters 
of low values in the outcome variable between a county and the neighbors); low-high (significant 
spatially autocorrelated clusters where the county has low value but the neighbors have high 
values in the outcome variable); and high-low (significant spatially autocorrelated clusters where 
the county has high value but the neighbors have low values in the outcome variable). Figure 2 
shows LISA clusters for the traditional method in both periods, and Figure 3 shows LISA 
clusters for the Empirical Bayes standardization method, also in both periods. Only the 
statistically significant associations are shown as colors in the map. 
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To determine whether the observed regression parameter estimates change significantly 
over time, the observations in the data set are stacked based on time for all the independent and 
dependent variables where time 0 indicates the earlier period and time 1 indicates late period. In 
addition, a stacked queen contiguity weight file is created based on time. Spatial regression 
analysis is conducted using GeoDa Space software on the stacked data file building on two time 
periods where time is used as a regime. First, the model is estimated using ordinary least square 
(OLS) using the time as a regime, and specifying separate variance-covariance matrix estimates 
in each time period, where two separate equations are shown for two periods. The residuals from 
OLS regression are used as the diagnostics for spatial regression, and a series of Lagrange 
multiplier tests (diagnostic tests for spatial dependence) are used to determine the correct 
specification model for spatial autocorrelation. The coefficients/parameter estimates and p values 
from the OLS regression along with the regression diagnostics are reported in the Table 4. 
Second, based on the Lagrange multiplier tests, a two stage least squares regression (lag 
model) is used for improved model specification. Two stage least square regression analysis 
allows separate parameter estimates in two different time period along with the spatial lag term 
(Rho) as a covariate (Anselin & Rey, 2014, p 159). For the heteroskedasticity issues in the OLS 
model, white correction is used in the lag model to get correct standard errors. Also, to address 
the observed lack of normality problem, method of moments (MOM) estimation is used instead 
of maximum likelihood estimation (MLE). Chow tests provide the information on whether any 
significant change is present over time, both a global change and individual changes in the 
coefficients associated with specific variables. The null hypothesis is that the coefficient 
estimates did not change over time. A rejection of the null hypothesis indicates that a significant 
change over time has occurred. All the diagnostic tests for spatial dependence (Lagrange 
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Multiplier tests and Anselin-Kelejian test) are shown in Table 5. Coefficients, p values and Chow 
tests results from the lag model are shown in Table 6.  
Lastly, based on the significant Anselin-Kelejian diagnostic test (shown in Table 5) on 
the residuals from the spatial lag model, a combined error and lag model / Durbin model is 
estimated (Anselin & Rey, 2014, p 259). Anselin-Kelejian test is a diagnostic test for spatial 
dependence in the lag model, which provides information on any remaining spatial 
autocorrelation after the lag model estimation (Anselin & Rey, 2014, p 300). The null hypothesis 
is that there is no remaining spatial autocorrelation in the model. A rejection of null hypothesis 
indicates that there is still spatial autocorrelation present, which can be corrected by a Durbin/ 
combo model estimation. This model incorporates both spatial lag coefficient (Rho), the 
coefficient for lagged dependent variable and error coefficient (Lamda), the coefficient for 
lagged independent variables in the predictor matrix. Method of moments (MOM) estimation is 
used here too, which is the default option for combo model. Also, the KP-HET option is used in 
this model for the heteroskedasticity issue. Coefficients and p values along with Chow test 
results are reported in the Table 7.  
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Chapter IV 
Results 
4.1 Descriptive analysis  
A total of 3,106 counties were included in the dataset for the analysis. Alaska, Hawaii 
and other islands, which are considered as spatial islands, are excluded from the analysis. 
Variable descriptions are presented in the Table 1, and descriptive statistics are presented in the 
Table 2 with mean and standard deviation. The mean drug overdose death rate of all counties 
included in the analysis increased from 9.42 ± 9.92 to 11.91 ± 11.58 (per 100,000) from earlier to 
later period. McDowell, West Virginia (death rate 88.9), Wyoming, West Virginia (death rate 
84.77) and Floyd, Kentucky (death rate 68.5) are the counties with highest drug overdose death 
rates in the earlier period, while in the later period, the counties with highest rates are again 
McDowell, West Virginia (death rate 85.61), Rio Arriba, New Mexico (83.64) and Wyoming, 
West Virginia (83.33). Comparison of rates in these two periods in the Figure 1 shows that the 
drug overdose rates increased over time, and became more geographically dispersed in the later 
period.  
4.2 Tests of spatial autocorrelation 
The Global Moran’s I statistic is statistically significant at p < 0.05 for drug overdose 
death rate for the both time periods. The statistic presented in Table 3 indicates the presence of 
substantial spatial autocorrelation somewhere across the map. The Global Moran’s I for 
Empirical Bayes standardized spatial clustering method demonstrates the same. 
LISA cluster maps shown in Figure 2 (for traditional method) and Figure 3 (for Empirical 
Bayes standardization method) indicate the presence of statistically significant positive clusters 
of high rates (hotspots) in red color and low rates (cool-spots) in blue color in drug overdose 
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death rates during both periods. For the early period, clusters of hot-spots are mostly located in 
the coastal West region (part of California, Oregon and Washington), part of Southwest region 
(part of Arizona and Oklahoma, big part of New Mexico), most of the upper and lower part of 
Southeast region (Tennessee, Kentucky, West Virginia, Florida, part of Georgia, South Carolina 
and North Carolina), a little part of Northeast region (Pennsylvania), and part of Midwest region 
(Ohio and Indiana). Cool spots are mostly located in the Midwest and Southwest regions. Hot-
spot distribution for Empirical Bayes standardization method in the earlier period demonstrates 
almost similar result. However, the distribution of cool-spots for Empirical Bayes 
standardization method is sparser than the traditional method along the Midwest region. For the 
later period, a shift of hotspot clusters is notable from Southeast to most of the Northeast region. 
While in the Southeast region there are no significant hotspots for Georgia and Florida for the 
later period; Kentucky, Tennessee, North Carolina and West Virginia still host significant 
hotspots. In addition, Oklahoma has more concentrated hotspots than before, and Colorado 
becomes the new location for hotspots. Cool spots become more significant along the middle 
part/ central plain area for the later period. LISA maps for Empirical Bayes standardization 
method for the later period show the similar distribution except for sparser cool-spots 
distribution along the middle part. 
4.3 Spatial regression results 
Table 4 shows the results from the first model, Ordinary Least Squares (OLS) estimation 
using time as a regime for two periods, and here all the predictors were used in both periods. 
Parameter estimates that are statistically significant at 5% level of significance are shown in bold 
font. Superscript C indicates the variable coefficients that significantly changed over time based 
on the Chow test. Global Chow test indicates an overall statistically significant change in effect 
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estimate over time. Regression diagnostics are also reported in this table. The diagnostics show 
that multicollinearity condition number is within the normative limits. However, the tests show 
lack of normality of errors and presence of heteroskedasticity in the model.   
Table 5 shows all the diagnostic tests for spatial dependence. The steps for searching 
correct spatial specification from the diagnostic tests are described here from Anselin & Rey, 
2014, p 110. If both the lag and error Lagrange multiplier (LM) tests are not significant, then 
robust tests are ignored and OLS results are kept without further changes. If both are significant, 
then the robust tests are examined and the one with a more significant test statistic is assumed the 
better model specification. Here in the Table 5, both lag and error LM tests are significant for 
both periods. Therefore, robust tests are examined. Robust LM test for lag is significant, while 
robust test for error is not. Hence, the lag model is the choice of model specification here.  
Table 6 shows the results of two stage least squares estimation (lag model). Results show 
a large positive lag parameter estimate (0.797 and 0.774 respectively for earlier and later period) 
which is significant in both periods with a p value of 0.000. This indicates a spillover effect 
across the county boundaries which means that neighboring counties have impact on the 
outcomes (death rates) of their neighbors. OLS model estimates are larger (biased upwards by 
spatial multiplier bias) than lag model estimates and the lag model is needed to address the 
spatial dependence issues. In Table 6, significant changes of effect estimates over time are 
indicated with the superscript C based on the Chow test results. The global Chow test indicates 
that there is a strong significant overall change in effect estimates over time (p-value 0.000) 
along with a few of the coefficients that show significant changes (unemployment rate, uninsured 
rate, poverty rate in Black rural and poverty rate in Hispanic rural).  
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The Anselin-Kelejian test in Table 5 indicates that, after spatial lag modeling there are 
still spatial autocorrelation effect present in the model. This additional spatial effect is from 
correlation of spatial error term (Anselin & Rey, 2014, p 259). The null hypothesis for this test 
is, no spatial effects are present. Rejection of this test indicates that a combined/ Durbin model is 
the best specification for the final model, with results shown in Table 7. Method of moments 
(MOM) estimation is the default option for this model. The KP-HET option is used because of 
strong indication of heteroskedasticity in the OLS model (Anselin & Rey, 2014, p 268). 
In Table 7, this Durbin model shows a significant negative error parameter estimate 
(Lamda), which is -0.581 and -0.524 respectively for earlier and later period with a p value of 
0.000. The lag parameter (Rho) remains the same as it was for the lag model in the both periods 
with high positive values along with statistically significant small p values. Among the parameter 
estimates- overall poverty rate (p value  for earlier period = 0.011, p value for later period = 
0.021), unemployment rate (p value for later period = 0.00), un-insured rate (0.00), poverty rate 
for Black rural (0.005, 0.000), poverty rate for Hispanic rural (0.000), poverty rate for White 
rural (0.001), poverty rate for White urban (0.000, 0.000) and population loss index (0.000, 
0.004) remained unchanged according to their significance across these two models (Lag and 
Durbin model). However, coefficients and significance for other variables have been changed. 
For example, poverty rate for Black urban becomes significant for both periods (0.002, 0.000) in 
the Durbin model instead of only later period in the lag model. Poverty rate for Hispanic urban 
becomes non-significant for both periods in the Durbin model, while it was significant for only 
earlier period in the lag model. 
Overall poverty rate is significant for both periods (p value 0.011 and 0.021) with 
positive coefficient indicating that higher drug overdose deaths are associated with increased 
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poverty. Unemployment rate has positive coefficients in the both periods, but is significant in the 
later period only (0.00) indicating that a higher unemployment rate is associated with increased 
deaths from drug overdose. The parameter estimates for the uninsured rate are negative in both 
periods, but significant in the earlier period (0.00). This indicates that the uninsured rate has a 
negative association with drug overdose rates meaning that more insurance coverage is 
associated with higher drug overdose deaths. The poverty rates for Black or White populations in 
urban areas have positive significant coefficients for both periods indicating that higher poverty 
in urban areas are associated with increased drug overdose deaths in these two groups of 
populations. Coefficients for the poverty rates for Hispanic populations in urban areas are not 
significant. For rural areas, the poverty rate for White populations also has positive coefficient, 
but significant only in the earlier period (0.001). However, for Black or Hispanic populations in 
the rural areas have negative association with drug overdose death rates, which is significant for 
both periods in Black (0.005, 0.000) and for the later period only in Hispanic (0.00) populations. 
This negative association indicates that increased poverty in rural areas is associated with less 
drug overdose deaths among these two groups of populations. Population loss index has negative 
coefficients and significant for both periods (0.00, 0.004). This indicates that counties that 
experience more population loss have less drug overdose deaths. 
In Table 7, significant change of effect estimates over time are indicated with the 
superscript C based on the Chow test results. Unemployment rate, uninsured rate, poverty rate in 
Black rural, poverty rate Hispanic rural and poverty rate in White rural are the variables for 
which the parameter estimates changed significantly over time. The global Chow test indicates 
that there is a strong statistically significant overall change in effect estimates over time (p-value 
0.000).
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Chapter V 
Discussion and Conclusion 
5.1 Spatial clusters for drug overdose deaths  
The United States is facing an epidemic of drug overdoses (Jalal et al., 2018). Using CDC 
WONDER database of mortality data, this paper focuses on drug overdose deaths, its spatial 
distribution across the United States at the county level and over time, and its associations with 
county level contextual factors. The study demonstrates that there was an increase in the drug 
overdose death rates over the two time periods. However, this increase was not consistently 
distributed across geography. For example, some counties had high rates in the earlier period, 
whereas for the later period these were very low. Thus, the distribution varied across the counties 
and dispersed over time. Death rates were mostly concentrated in the part of coastal areas of 
West region, part of the Southeast and Northeast regions in the earlier periods, whereas these 
spread to cover most of the West, Southwest, and Northeast regions and through the Midwest 
region in the later period.  
This study also reveals that there is significant spatial autocorrelation present among the 
adjacent counties in the drug overdose death rates which answers the first research question. 
Both traditional method and Empirical Bayes standardization method of drug overdose deaths 
are used to test for spatial association. Few previous studies mentioned using the Empirical 
Bayes method for heroin or other drug poisoning death rates due to it being an infrequent event 
or having small population size to smooth the data (Rossen, Khan, & Warner, 2014; Stewart, 
Cao, Hsu, Artigiani, & Wish, 2017). In this study, both methods show similar patterns of spatial 
clustering across the map. However, this spatial cluster pattern differs in two time periods. For 
example, statistically significant positive clusters of high rates (hotspots) are in the coastal part 
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of West region, part of Southwest and Northeast regions, and most of Southeast region in the 
earlier period for both methods. On the other hand, in the later period, these hotspots spread to 
cover most of West, Southwest and Northeast regions, part of the Midwest region, and lesser part 
of Southeast region than before, with the Northeast region experiencing the greatest increase, 
again demonstrated by both methods.  
Furthermore, there is a little difference in the significant clusters for low rates (cool-
spots) between these two methods. Cool-spots for the Empirical Bayes standardization method 
are a little sparser than the traditional method. While the primary idea of using the Empirical 
Bayes standardization method is to get rid of spurious outliers and alleviate small area problems 
due to varying population densities when considering calculation of rate or proportion variable 
(GeoDa, n.d.), one could expect a broader pattern for Empirical Bayes standardization method if 
there was a problem with small denominators. However, this does not seem to be the case in this 
study as maps from both methods look similar. One reason behind this can be that the data set 
used in this study does not have small population problem, that means data is not disperse 
enough to get a significant difference. The Empirical Bayes standardization method can correct 
for the rates where data are too dispersed. Since this study used 5-years aggregated data from the 
database to get values for more counties, this could reduce this problem by having less disperse 
data.  
5.2 Spatial regression    
Presence of spatial autocorrelation among the adjacent counties in the drug overdose 
death rates is taken into consideration with the regression modeling. After several 
misspecification tests are run, a correct model is specified to describe the difference in the 
outcome of drug overdose deaths as predicted through some socioeconomic and 
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sociodemographic predictors. The multicollinearity number is within normative limits. However, 
due to a skewed outcome variable (shown in Figure 4) there are issues with non-normality and 
heteroskedasticity, which are handled with method of moments (MOM) estimation, and white 
and KP-HET correction tests for standard errors.  
The results suggest that the effect of different contextual factors are heterogenous over 
time and across different population. The overall poverty rate at the county level is found to have 
a significant positive association with drug overdose death rates in both periods; that means 
counties with higher poverty rates have higher drug overdose death rates. This finding is 
consistent with prior studies which found that high poverty in the county have impact on the 
positive relationship between higher prescription rates and opioid related deaths (Cerdá et al., 
2017; Grigoras et al., 2018). 
The results also suggest that the uninsured rate has a negative association with drug 
overdose deaths. That means counties with greater insurance coverage have higher drug 
overdose death rates, which may be due to the association of drug overdose with increased 
prescription pain medication. The study by Grigoras et al. (2018) focused on the prescription 
behavior of physicians where they found positive associations between higher rates of 
prescription containing opioids and opioid related deaths. It is noteworthy that pharmaceutical 
opioids were responsible for 37% of the total 44,000 drug overdose deaths in 2013 (Grigoras et 
al., 2018). This implies that legal availability of drugs through insurance policies can be a driving 
factor for drug overdose death. Therefore, more insurance coverage can lead to more exposure to 
prescription pain medications which might be a source of drug overdose. 
In addition, insurance coverage difference resulting from Affordable Care Act (ACA) 
between these two time intervals can highlight on mechanism behind it. This is commensurate 
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with studies that demonstrated that Affordable Care Act specifically through Medicaid expansion 
offers uninsured and vulnerable populations better access to health care, more prescription 
medications, and less out-of-pocket spending (Mulcahy, Eibner, & Finegold, 2016; 
Mahendraratnam, Dusetzina, & Farley, 2017). This policy is specifically for people with chronic 
conditions who need more pain medications. Again, most insurers have a policy of giving easy 
access or coverage for generic opioid medication as pain reliever which are cheaper but 
potentially addictive. On the other hand, safer alternatives with less-risky and less-addictive 
opioids have limited access and are expensive (Analysis, 2017). Thus, it seems that sometimes 
insurance coverage cannot help in controlling the epidemic situation due to the restricted policies 
of the insurers. All these mechanisms together are responsible, suggesting that effective 
implementation of insurance policy can be the primary focus of intervention and policy. 
The unemployment rate is found to be significantly positively associated with the drug 
overdose deaths in the later period indicating that an increase in county level unemployment rate 
is associated with increased death from drug overdose that is consistent with the findings of 
Carpenter, McClellan, & Rees (2017) and Brown & Wehby (2017). Losing a job creates 
frustration, stress, social isolation, and even depression which in turn leads to substance abuse or 
increased use of pain medication (McLean, 2016). 
Another notable association is poverty rate by race/ethnicity and urbanization. Spatial 
pattern of association between White populations and drug overdose death rates suggest that 
poverty rate in both urban and rural areas are positively associated with drug overdose deaths. 
These associations are significant in both periods for urban areas and only in the earlier period 
for rural areas. That means for White populations, higher poverty rate is associated with greater 
drug overdose deaths regardless of the locations. Indeed, a previous study documented that areas 
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with higher opioid prescription rates have higher percentage of White populations and which is 
associated with higher opioid related mortality (Grigoras et al., 2018). They also found rural 
areas to have higher prescription rates. However, this paper demonstrates association in both 
rural and urban areas. Therefore, the underlying mechanism seems to be multifactorial. This is 
evident when we look at the poverty rate for Black and Hispanic populations in rural areas which 
is negatively associated with drug overdose deaths; whereas poverty rate in urban areas for the 
same populations is positively associated. That means, in rural areas this effect is opposite, 
where Black and Hispanic populations in areas with higher poverty level might have less 
exposure to the drug overdose. On the other hand, in urban areas poverty in Black populations 
has significant associations with higher drug overdose deaths, though this association is not 
significant for poverty in Hispanic populations. Population loss index has negative coefficients 
and significant for both periods. This means counties experiencing population loss have lower 
drug overdose deaths.  
5.3 Limitations and strengths 
One limitation is that the dataset used here for the outcome variable has a good number of 
suppressed data for privacy policy, which causes the outcome variable to be skewed. This may 
impact the death rate estimation and model specification. Having more accurate counts instead of 
suppressed data would be helpful to get a better inference. However, this paper uses method of 
moments (MOM) to address the issue of non-normally distributed outcomes, which is 
recommended in this case (Anselin & Rey, 2014). An additional strength is that this study uses 
population level data which is spatially representative at the county level and uses spatial 
analysis to address spatial impacts. Another limitation is that this study does not take into 
consideration of different age groups in the outcome variables. We know that insurance coverage 
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and prescription patterns vary in different age groups. For example, Grigoras et al. (2018) found 
higher opioid prescription rates among people with >65 years of age and Medicare populations 
which can be related to associated mortality. In addition, the relationship of pharmaceutical 
industries’ role with prescription patterns by the physicians in terms of insurance coverage is not 
taken into consideration either. On the other hand, this paper uses all drug overdose deaths that 
includes deaths from all types of drug classes so that it can provide a common idea for all types 
of drugs; thus, cost-effective policies for areas with greater needs, and easier ways for awareness 
campaign. 
5.4 Implications and future directions  
This study informs how drug overdose death rates are changing over time and geographic 
areas. This shows the areas with growing mortality burdens which can be compared over time. 
This finding is enriched with associated socioeconomic and sociodemographic factors which 
may help to address the areas with greater needs. This can be interesting for the researchers who 
are interested to see the effect of economy and policy on the outcome. Future studies having 
lesser suppressed data and more contextual factors can provide a better vision. Also, study 
focusing on different age groups and gender may serve valuable functions. Another focus area 
can be pharmaceutical industries’ role on pain medication prescription patterns among different 
insured groups. Further in-depth analysis on these areas might provide with awareness and 
valuable information for controlling the epidemic situation for policymakers and future 
researchers. 
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Appendix: Tables and Figures 
Table 1 
Variables used for this study, description, metric, sources and years. All the variables are aggregated over two time intervals at 
county level 
 
Variable name Description Metric  Sources Years 
Outcome variable     
Drug overdose death rates Proportion of population died from 
drug overdose according to their death 
certificates by county aggregated over 
2007-2011 and 2012-2016 
Continuous “Underlying cause of 
death, 1999-2016” from 
CDC WONDER website 
2007-2011  
(Early) & 
2012-2016 
(Late) 
Predictor variables     
     Un-insured rate  Percent un-insured total population 
<65 years, early and late. 
Continuous US Census Bureau, SAHIE 
program 
2005 (Early) & 
2014 (Late) 
 
              Unemployment rate Proportion of unemployed population, 
early and late. 
Continuous 
 
Bureau of Labor Statistics, 
LAUS program 
2005 (Early) & 
2015 (Late) 
             Overall poverty rate Estimated percent of total population 
in poverty for the income year, early 
and late 
Continuous 
 
US Census Bureau, 
SAIPE program 
2005 (Early) & 
2014 (Late) 
 Poverty rate for Black rural 
 Poverty rate for Black urban 
 Poverty rate for Hispanic rural 
 Poverty rate for Hispanic urban 
 Poverty rate for White rural 
 Poverty rate for White urban 
Proportions of total population for 
whom poverty data exists for particular 
race/ ethnicity and urbanicity, early 
and late 
Continuous 
 
Calculated by GeoDa 
center 
 
2000 (Early) 
& 
2005-2009 
aggregated (Late) 
 
         Population loss index The variable indicating whether 
counties experiencing population loss 
or not, early and late 
Dichotomous 
1=Yes, 0=No 
Economic Research 
Service (ERS) of USDA 
 
2004 (Early) & 
2015 (Late) 
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Table 2  
Descriptive statistics for all county-level variables used in the model 
Time Interval      Early period 
    (N=3106 counties) 
       Later period  
      (N= 3106 counties) 
Variables Mean SD  Mean SD 
Drug overdose death rate 9.42 9.92 11.91 11.58 
Un-insured rate 17.99 6.1 14.33 5.09 
Unemployment rate  5.37 1.78 5.49 1.95 
Poverty rate for rural Black 2.0 4.64 2.03 4.63 
Poverty rate for urban Black 0.62 1.95 0.66 1.99 
Poverty rate for rural Hispanic 1.14 2.98 1.39 3.15 
Poverty rate for urban Hispanic 0.46 1.72 0.55 1.75 
Poverty rate for rural White 7.87 5.26 8.41 5.51 
Poverty rate for urban White 1.26 2.15 1.43 2.48 
Overall poverty rate 15.34 6.52 16.87                 6.46 
Counties with population loss 599 (count) 19.29% 525 (count) 16.9% 
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Table 3  
Moran’s I statistics for spatial autocorrelation for drug overdose death rates in early & late 
period (both traditional method and Empirical Bayes standardization method) 
 Moran’s I  Z-value  P value 
Variable Traditional 
method 
EB 
method 
 Traditional 
method 
EB 
method 
 Traditional 
method 
EB 
method 
Drug overdose 
death rate 
(Early) 
0.53 0.52  49.16 47.66  0.001 0.001 
Drug overdose 
death rate 
(Late) 
0.55 0.54  50.84 50.55  0.001 0.001 
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Table 4  
Model 1: Regression output from OLS (Ordinary Least Square) model with regression 
diagnostics 
 Earlier period Later period 
Variable Coefficient P value Coefficient P value 
CONSTANTC 3.819 0.000 0.674 0.421 
Poverty rate 0.046 0.383 0.085 0.114 
Population LossC -5.479 0.000 -4.075 0.000 
Unemployment rateC 0.799 0.000 2.083 0.000 
Un-insured rate -0.253 0.000 -0.149 0.001 
Poverty rate in Black ruralC -0.248 0.000 -0.722 0.000 
Poverty rate in Black urban 0.337 0.001 0.213 0.049 
Poverty rate in Hispanic 
ruralC 0.009 0.914 -0.375 0.000 
Poverty rate in Hispanic 
urbanC 0.191 0.081 -0.203 0.093 
Poverty rate in White ruralC 0.611 0.000 0.197 0.000 
Poverty rate in White urban 1.267 0.000 1.035 0.000 
Regression Diagnostics     
Multicollinearity number 15.847  15.618  
Normality of errors  2843.073 0.000 1589.124 0.000 
Heteroskedasticity 1404.397 0.000 1137.679 0.000 
 451.488 0.000 444.662 0.000 
Regimes diagnostics     
Global Chow Test            109.827 0.000   
Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the 
bold font. Superscript C denotes significant change in coefficients over time for the variables at 
5% significance level. Global Chow test indicates the overall change of effect over time. 
• Test for Normality of errors: Jarque-Bera test 
• Tests for Heteroskedasticity: Breusch-Pagan test and Koenker-Bassett test 
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Table 5 
Diagnostics for spatial dependence (Lagrange Multiplier tests and Anselin-Kelejian test) 
 
 Earlier Period Later Period 
Tests  Coefficient P value Coefficient P value 
LM Lag (RSρ) 1550.738 0.000 1490.997 0.000 
Robust LM Lag 
(RSρ*) 
205.254 0.000 234.046 0.000 
LM Error (RSλ) 1347.599 0.000 1258.232 0.000 
Robust LM Error 
(RSλ*) 
2.114 0.146 1.281 0.258 
Anselin- Kelejian 
test 
39.652 0.000 36.166 0.000 
Note: LM= Lagrange Multiplier Test. Methodology for steps of diagnostics testing for spatial 
dependence to determine correct model specification (Anselin & Rey, 2014, p.110) is described 
in the result chapter
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Table 6  
Model 2: Regression output from spatial two stage least squares estimation (Lag model) 
 
 Earlier period Later period 
Variable Coefficient P value Coefficient P value 
CONSTANTC 2.282 0.001 -1.597 0.019 
Poverty rate 0.081 0.038 0.097 0.028 
Population Loss -1.404 0.000 -0.906 0.034 
Unemployment rate C -0.011 0.916 0.471 0.001 
Un-insured rate C -0.198 0.000 -0.033 0.383 
Poverty rate in Black ruralC -0.094 0.026 -0.267 0.000 
Poverty rate in Black urban 0.121 0.101 0.196 0.013 
Poverty rate in Hispanic 
ruralC 0.033 0.591 -0.205 0.001 
Poverty rate in Hispanic urban 0.151 0.045 0.075 0.403 
Poverty rate in White rural 0.174 0.002 0.042 0.421 
Poverty rate in White urban 0.658 0.000 0.614 0.000 
Spatial lag of Death Rate (ρ) 0.797 0.000 0.774 0.000 
Regimes Diagnostics     
Global Chow test 38.610 0.000   
Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the 
bold font. Superscript C denotes significant change in coefficients over time for the variables at 
5% significance level. Global Chow test indicates the overall change of effect over time. 
• White correction test is used to correct the standard errors for heteroskedasticity issue 
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Table 7  
Model 3: Regression output from spatially weighted two stage least squares estimation 
(Combo/ Durbin model) 
 
 Earlier period Later period 
Variable Coefficient P value Coefficient P value 
CONSTANTC 0.966 0.032 -1.805 0.001 
Poverty rate 0.075 0.011 0.083 0.021 
Population Loss -1.572 0.000 -1.101 0.004 
Unemployment rate C 0.012 0.877 0.514 0.000 
Un-insured rate C -0.127 0.000 -0.011 0.698 
Poverty rate in Black ruralC -0.089 0.005 -0.269 0.000 
Poverty rate in Black urban 0.187 0.002 0.239 0.000 
Poverty rate in Hispanic 
ruralC 0.016 0.729 -0.177 0.000 
Poverty rate in Hispanic urban 0.112 0.071 -0.014 0.863 
Poverty rate in White rural C 0.158 0.001 0.035 0.402 
Poverty rate in White urban 0.596 0.000 0.561 0.000 
Spatial lag of Death Rate (ρ) 0.824 0.000 0.784 0.000 
Error term (Lamda) -0.581 0.000 -0.524 0.000 
Regimes Diagnostics     
Global Chow test 40.657 0.000   
Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the 
bold font. Superscript C denotes significant change in coefficients over time for the variables at 
5% significance level. Global Chow test indicates the overall change of effect over time. 
• The KP-HET option is used in this model because of heteroskedasticity issues in the OLS 
model. 
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Figure 1 
Drug overdose death rates per 100,000 during early (2007-2011) and late (2012-2016) periods 
using the same cut points 
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Figure 2 
Spatial patterns of drug overdose death rates during early (2007-2011) and late (2012-2016) 
periods, queen contiguity weight is used (Traditional method) 
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Figure 3 
Spatial patterns of drug overdose death rates during early (2007-2011) and late (2012-2016) 
periods, queen contiguity weight is used (Empirical Bayes Standardization method) 
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Figure 4 
Histogram of drug overdose death rates (early and late) 
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 Supplementary Material 
Table   
Model 2: Regression output from spatial two stage least squares estimation (Lag model) – 
without White correction test 
 Earlier period Later period 
Variable Coefficient P value Coefficient P value 
CONSTANTC 2.282 0.001 -1.597 0.016 
Poverty rate 0.081 0.048 0.097 0.021 
Population Loss -1.404 0.000 -0.906 0.029 
Unemployment rate C -0.011 0.904 0.471 0.000 
Un-insured rate C -0.198 0.000 -0.033 0.379 
Poverty rate in Black ruralC -0.094 0.045 -0.267 0.000 
Poverty rate in Black urban 0.121 0.121 0.196 0.021 
Poverty rate in Hispanic 
ruralC 0.033 0.594 -0.205 0.000 
Poverty rate in Hispanic urban 0.151 0.077 0.075 0.431 
Poverty rate in White rural C 0.174 0.001 0.042 0.328 
Poverty rate in White urban 0.658 0.000 0.614 0.000 
Spatial lag of Death Rate 0.797 0.000 0.774 0.000 
Regimes Diagnostics     
Global Chow test 35.552 0.000   
Note: Statistically significant effect estimates at significance level of 0.05 are highlighted in the 
bold font. Superscript C denotes significant change in coefficients over time for the variables at 
5% significance level. Global Chow test indicates the overall change of effect over time. 
 
